Kincell Bio is a CDMO that develops and manufactures immunotherapies, including autologous and allogeneic CAR-T, CAR-NK, and CAR-M programs. Based in Gainesville, Florida, Kincell specializes in early-stage cell therapy development and manufacturing and provides analytical development, process development, CMC consulting, and early-stage GMP cell therapy manufacturing to their partners. Founded in 2023, Kincell is a spinout of Inceptor Bio, a North Carolina cell therapy biotech.
